Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing
Utility Patent
1999-03-04
2001-01-02
Killos, Paul J. (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Amino nitrogen containing
C564S308000
Utility Patent
active
06169205
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates to a method for the purification of (RR,SS)-2-(dimethylamino)methyl-1-(3-methoxyphenyl)cyclohexanol (also named trans-(±)-2-(dimethylamino)methyl-1-(3-methoxyphenyl)-cyclohexanol) based on a selective crystallization procedure.
BACKGROUND OF THE PRIOR ART
(RR,SS)-2-(Dimethylamino)methyl-1-(3-methoxyphenyl)cyclohexanol in the form of hydrochloride is an active ingredient belonging to the class of analgesics, which has been used in therapy since 1978, under the non-proprietary name Tramadol (Schenk, E. G.; Arend, I.
Drugs
1978, 28, 209). More particularly, this compound is used against acute and chronic pains, as it acts on opioid receptors and inhibits serotonin and noradrenalin reuptake. Compared with other medicaments of the same class, it interestingly causes comparatively low tolerance (Preston, K. L.; Jasinski, D. R.; Testa, M.
Drug and Alcohol Dependence
1991, 27, 7) and poor side effects (Cossmann, M.; Kohen, C.
Rev. Contemp. Pharmacother.
1995, 513). However, the product should be highly pure for these therapeutical effects to take place. The synthetic method comprises reacting 3-bromo-anisole via Grignard reagent with 2-dimethylaminophenyl-cyclohexanone to give the two diastereomers (RS,SR)- and (RR,SS)-2-(dimethylamino)methyl-1-(3-methoxyphenyl)cyclohexanol in ratios ranging from 30/70 to 85/15. The purification of the trans form from the cis form is critical for the preparation of Tramadol for the pharmacological use. The known methods are substantially two:
1. A process which makes use of dioxane to recrystallize the hydrochloride of the diastereomeric mixture (Von Frankus, E.; Friderichs, E.; Kim, S. M.; Osterloh, G.
Arneim.Forsch.Drug Res.
1978, 28, 114; Flick et al. U.S. Pat. No. 3,652,589). Dioxane is however a toxic solvent, which involves safety problems when used in industrial plants as well as very low tolerance limits on the end product (<5 ppm).
2. The selective precipitation of the trans isomer by preparing the hydrochloride of the Grignard reaction crude by means of gaseous HCl in solvents such as alcohols, ketones, esters etc. (U.S. Pat. No. 5,414,129, Chemagis). On the other hand, as it is evidenced in the experimental section, this method yields a product which cannot be marketed and used in therapy. The resulting hydrochloride has to be repeatedly recrystallized.
SUMMARY OF THE INVENTION
It now has been found that (RR,SS)-2-(dimethylamino)methyl-1-(3-methoxyphenyl)cyclohexanol III can be recovered as crystalline solid from a solvent consisting of water and a water-miscible organic solvent such as acetone, DMF, ethanol, methanol, THF. The recovery of (RR,SS)-2-(dimethylamino)methyl-1-(3-methoxyphenyl)-cyclohexanol of formula III as a solid is surprising in that the very same product had been described to be a liquid (Flick et al.; U.S. Pat. No. 3,652,589), and it is advantageous since it makes the purification from the other isomer easier, as the latter is oily. Therefore, the solid isomer can be removed selectively from (RS,SR)-2-(dimethylamino)methyl-1-(3-methoxyphenyl)-cyclohexanol of formula IV.
The selective precipitation according to the invention takes place using mixtures of water and water-miscible organic solvent in ratios ranging from 9:1 to 1:9 respectively, preferably of about 1:1.
Preferred organic solvents are C
1
-C
3
alcohols (methanol, ethanol, isopropanol), acetone, methyl ethyl ketone, dimethylformamide, tetrahydrofuran, diglyme, glycols, preferably methanol, ethanol, acetone and tetrahydrofuran.
The crystallization temperature is not critical, but it will generally range from 10° C. to −40° C.
The crude is obtained by preparation of 3-bromo-anisole Grignard reagent II and subsequent condensation with 2-dimethylaminomethyl cyclohexanone I according to the procedure disclosed in U.S. Pat. No. 3,652,589.
The process of the invention is illustrated in the following scheme.
REFERENCES:
patent: 3652589 (1972-03-01), Flick et al.
patent: 5414129 (1995-05-01), Cherkez
patent: 0778262 (1997-06-01), None
patent: 0831082 (1998-03-01), None
Cabri Walter
Magrone Domenico
Bucknam and Archer
Dipharma S.p.A.
Killos Paul J.
LandOfFree
Process for the purification of (RR,SS)-2-(dimethylamino)... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for the purification of (RR,SS)-2-(dimethylamino)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the purification of (RR,SS)-2-(dimethylamino)... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2512702